Physician

Douglas S Spurgeon, M.D.

According to 2025 Medicare claims, Douglas Spurgeon, M.D. (NPI: 1215903463) practices pain management in the Lincoln, NE market, with the plurality of this provider's patient population coming from Lancaster, NE. This provider's primary affiliated billing organization is NEBRASKA PAIN INSTITUTE, LLC (NPI: 1881181816; TIN: 824615238) and primary practice location at 68516-7783. Spurgeon is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287), Bryan Health Connect ACO, LLC (ACO ID: A4573), and Main Street Rural Health Maple ACO LLC (ACO ID: A5401), participating under the MSSP model.

Spurgeon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,004 traditional Medicare patients, billed 29,002 HCPCS/CPT codes, and received $403,760 in Medicare payments. The top billing code was 27096 (Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance). Part D data shows 4,407 prescription claims across 655 beneficiaries totaling $302,038 in drug costs, led by Belbuca (Buprenorphine Hcl). Open Payments data shows 106 records totaling $24,403. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $21,092 to $403,760. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	164	230	$21,092
2016	160	229	$19,132
2017	181	249	$19,969
2018	191	284	$26,264
2019	212	286	$27,149
2020	268	7,831	$214,597
2021	336	10,293	$280,843
2022	457	11,726	$309,358
2023	799	22,984	$403,334
2024	1,004	29,002	$403,760

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	262	2,051	$100,674
2021	438	4,997	$381,843
2022	552	5,902	$472,592
2023	599	4,285	$305,215
2024	655	4,407	$302,038

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
27096	Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance	172	277	$142
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	157	157	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	759	1,297	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	195	239	$59
J1100	Injection, dexamethasone sodium phosphate, 1 mg	327	9,490	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Belbuca	Buprenorphine Hcl	64	1,821	$59,076
Nucynta	Tapentadol Hcl	16	427	$36,334
Oxycontin	Oxycodone Hcl	29	870	$23,741
Qulipta	Atogepant	18	514	$19,428
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	484	12,897	$16,725

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	106	$24,403	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Douglas S. Spurgeon, M.D.?

Tedicare shows public-source Medicare data for Douglas S. Spurgeon, M.D. (NPI 1215903463), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Douglas S. Spurgeon, M.D. have ACO affiliation data?

Douglas S. Spurgeon, M.D. is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287), Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573), and Main Street Rural Health Maple ACO LLC (MSSP, ACO ID A5401).

What billing organization is linked to Douglas S. Spurgeon, M.D.?

Douglas S. Spurgeon, M.D. is linked to NEBRASKA PAIN INSTITUTE, LLC (billing NPI 1881181816) in the available physician profile data.

Does Douglas S. Spurgeon, M.D. have Open Payments data?

Douglas S. Spurgeon, M.D. has 106 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.